Inactive Instrument

Conformis, Inc.

Equities

CFMS

US20717E2000

Medical Equipment, Supplies & Distribution

Conformis, Inc., Announces Resignation of Patricia Davis as Chief Legal Officer

April 24, 2019 at 04:07 pm EDT

On April 22, 2019, Patricia Davis, JD, Chief Legal Officer, of Conformis, Inc. announced her resignation from the company. In connection with her departure, Ms. Davis will cease to serve as an executive officer (as such term is defined in Rule 3b-7 of the Securities Exchange Act of 1934) of the company, effective May 17, 2019.

Latest news about Conformis, Inc.

Conformis, Inc. Announces Board Changes	23-09-05	CI
Conformis, Inc.(NasdaqCM:CFMS) dropped from NASDAQ Composite Index	23-09-05	CI
Restor3D, Inc. completed the acquisition of Conformis, Inc. from shareholders.	23-09-04	CI
Conformis, Inc.(NasdaqCM:CFMS) dropped from S&P TMI Index	23-09-01	CI
Conformis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Earnings Flash (CFMS) CONFORMIS Posts Q2 Revenue $13M	23-08-02	MT
Sector Update: Health Care Stocks Lower Late Friday	23-06-23	MT
Sector Update: Health Care	23-06-23	MT
Top Midday Gainers	23-06-23	MT
Global markets live: 3M Company, Meta, Moderna, Carmax, Shell...	23-06-23
It just won't go away	23-06-23
Sector Update: Health Care Stocks Decline Premarket Friday	23-06-23	MT
Wall Street Set to Open Lower Ahead of June's Flash PMI; Oil Prices Drop Sharply	23-06-23	MT
Sector Update: Health Care	23-06-23	MT
US Futures Trend Lower Premarket Friday Ahead of June's Flash PMI	23-06-23	MT
Top Premarket Gainers	23-06-23	MT
ConforMIS Agrees to be Acquired by restor3d	23-06-23	MT
Restor3D, Inc. entered into a definitive merger agreement to acquire Conformis, Inc. from shareholders for $17.9 million.	23-06-21	CI
Conformis, Inc. Announces Resignation of Robert S. Howe as Treasurer, Effective June 9, 2023	23-05-19	CI
Conformis, Inc. Announces Chief Financial Officer Changes, Effective June 9, 2023	23-05-19	CI
Conformis, Inc. Announces Board Changes	23-05-10	CI
Oppenheimer Downgrades ConforMIS to Perform From Outperform, Removes $6 Price Target	23-05-09	MT
Transcript : Conformis, Inc., Q1 2023 Earnings Call, May 08, 2023	23-05-08
Conformis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Earnings Flash (CFMS) CONFORMIS Reports Q1 Revenue $12.8M, vs. Street Est of $12.6M	23-05-08	MT

Chart Conformis, Inc.

Duration

Period

More charts

Company Profile

Conformis, Inc. is a medical technology company. The Company is engaged in the development, manufacturing, and sales of patient-specific products and instrumentation that are individually sized and shaped to fit each patient's various knee and hip anatomy. The Company offers knee replacement products and knee replacement products. The Company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program, as well as data-informed, standardized solutions that combine many benefits of personalization with an off-the-shelf system. Its sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. The Company owns or in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-30 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+10.11%	126B
SMITH & NEPHEW PLC	-5.15%	11.33B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+6.07%	9.27B
GLAUKOS CORPORATION	+37.46%	5.5B
AXONICS, INC.	+8.53%	3.45B
ENOVIS CORPORATION	-8.69%	2.81B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-6.38%	2.08B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.91%	2.09B
DOUBLE MEDICAL TECHNOLOGY INC.	-23.21%	1.78B

Medical Devices & Implants